Inspiratory Muscle Training in Patients Receiving Allogenic Stem Cell Transplantation

Elisabethinen Hospital

Status: Unknown

Conditions: Stem Cell Transplantation; Respiratory Muscle Training; Inspiratory Muscle Training

Treatments: Other: inspiratory muscle training; Procedure: Inspiratory Muscle Training

Study type: Interventional

Funder types: Other

Identifiers

NCT01281410

EK 462

Details and patient eligibility

About

The study is a monocentric, controlled randomized trial. Its an interventional method study. There is a control and an interventional group. The interventional group is receiving a specific inspiratory muscle training with "Respifit" (special device for inspiratory muscle training) during the first 30 days after allogenic stem cell transplantation.

The investigators want to show that the training group gets stronger inspiratory muscles. The investigators measure the change of PIMAX values and MVV values.

Enrollment: 106 estimated patients

Sex: All

Ages: 17 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients receiving allogenic stem cell transplantation
• Age 17 - 80 years old
• Informed consent

Exclusion criteria

• Actual pneumonia at the beginning of the trial
• Impaired vision
• Patient is not able to handle "Respifit"

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

106 participants in 2 patient groups

Standard physiotherapy

No Intervention group

Description:

Standard Physiotherapy without Inspiratory Muscle Training

Inspiratory muscle training

Experimental group

Description:

Inspiratory muscle training with a device named Respifit in addition to the usual physiotherapy program

Treatment:

Other: inspiratory muscle training

Procedure: Inspiratory Muscle Training